← 전체 보충제 목록

모다피닐 (처방 참조)

Modafinil (Rx-only reference)

📑 PubMed 39편 🌙 수면·인지

📚 관련 논문 (30편)

1.
The wake of addiction: Pharmacological strategies for sleep disturbances in stimulant use disorders, a systematic review.
Drug and alcohol dependence 2026 PMID:41855890

1. Drug Alcohol Depend. 2026 Jun 1;283:113125. doi: 10.1016/j.drugalcdep.2026.113125. Epub 2026 Mar 13. The wake of addiction: Pharmacological strategies for sleep disturbances in stimulant use disorders, a systematic review. Bourtin IG(1), Calvillo DJ(2), Badawi JC(3), Schmitz JM(4), Lane SD(5)

2.
Improving Cognition in Bipolar Disorder: A Systematic Review of Current Pharmacological and Nutraceutical Approaches.
Neuropsychobiology 2026 PMID:41843701

2. Neuropsychobiology. 2026 Mar 17:1-24. doi: 10.1159/000551232. Online ahead of print. Improving Cognition in Bipolar Disorder: A Systematic Review of Current Pharmacological and Nutraceutical Approaches. Yalin N, Yildiz A. INTRODUCTION: Cognitive impairment is a core feature of bipolar disord

3.
Interventions for fatigue management after traumatic brain injury.
The Cochrane database of systematic reviews 2026 PMID:41700575

3. Cochrane Database Syst Rev. 2026 Feb 17;2(2):CD006448. doi: 10.1002/14651858.CD006448.pub2. Interventions for fatigue management after traumatic brain injury. Senior HE(1), Leung JH(2)(3), Meehan B(4), Leao S(2), Jordan V(5), Barker-Collo S(2), Crummey S(2), Purdy SC(2)(3). Author informatio

4.
Assessing Condition-Specific Adverse Event Profiles of Modafinil for Labelled and Off-Label Uses: A Systematic Review and Meta-Analysis.
Basic & clinical pharmacology & toxicology 2026 PMID:41367108

4. Basic Clin Pharmacol Toxicol. 2026 Jan;138(1):e70147. doi: 10.1111/bcpt.70147. Assessing Condition-Specific Adverse Event Profiles of Modafinil for Labelled and Off-Label Uses: A Systematic Review and Meta-Analysis. Jung J(1), Youm J(2), Kang J(3), Kim AY(4), Suh JK(5), Kang HY(1). Author inf

5.
Comparative efficacy of new wake-promoting agents for narcolepsy-a network meta-analysis.
BMC neurology 2025 PMID:41233821

5. BMC Neurol. 2025 Nov 13;25(1):466. doi: 10.1186/s12883-025-04328-9. Comparative efficacy of new wake-promoting agents for narcolepsy-a network meta-analysis. Yan Z(1), Li J(1), Yu Y(1), Qiu S(1), Wang B(1), Tang J(2). Author information: (1)Department of Neurology, the First Affiliated Hospit

6.
Pharmacological treatment options for cognitive dysfunction induced by multiple sclerosis: a network meta-analysis.
Frontiers in neurology 2025 PMID:41127289

6. Front Neurol. 2025 Oct 7;16:1649429. doi: 10.3389/fneur.2025.1649429. eCollection 2025. Pharmacological treatment options for cognitive dysfunction induced by multiple sclerosis: a network meta-analysis. Fan Z(1), Liu D(1), Zhang G(1), Guo X(1). Author information: (1)Department of Neurology

7.
Maternal and offspring outcomes associated with prescribed ADHD medication in pregnancy: a systematic review.
Archives of women's mental health 2025 PMID:41083615

7. Arch Womens Ment Health. 2025 Dec;28(6):1425-1446. doi: 10.1007/s00737-025-01621-x. Epub 2025 Oct 14. Maternal and offspring outcomes associated with prescribed ADHD medication in pregnancy: a systematic review. Tai S(1), Patel S(2), Downes K(1), Rogers J(3)(4), Chu-Han Huang H(5)(6). Author

8.
The evidence for treatments for postural orthostatic tachycardia syndrome: a systematic review of randomized trials.
Trends in cardiovascular medicine 2025 PMID:40653179

8. Trends Cardiovasc Med. 2025 Nov;35(8):517-527. doi: 10.1016/j.tcm.2025.07.001. Epub 2025 Jul 11. The evidence for treatments for postural orthostatic tachycardia syndrome: a systematic review of randomized trials. Kwok CS(1), Lee S(2), Hall M(3), Qureshi AI(4), Lip GYH(5), Loke YK(6), Raj SR

9.
Narcolepsy: a machine learning bibliometric analysis (1996-2024).
Frontiers in neurology 2025 PMID:40642209

9. Front Neurol. 2025 Jun 25;16:1505574. doi: 10.3389/fneur.2025.1505574. eCollection 2025. Narcolepsy: a machine learning bibliometric analysis (1996-2024). Zhang M(1), Hu X(2), Wu H(1), Fan H(2). Author information: (1)First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. (2)The

10.
Modafinil/armodafinil for excessive daytime sleepiness after traumatic brain injury: a systematic review and meta-analysis.
Brain injury 2025 PMID:40388311

10. Brain Inj. 2025 Aug;39(11):933-941. doi: 10.1080/02699052.2025.2502424. Epub 2025 May 19. Modafinil/armodafinil for excessive daytime sleepiness after traumatic brain injury: a systematic review and meta-analysis. João RB(1), Pacheco-Barrios N(2)(3), Leite M(4), Gonçalves Soares YRR(5), Eylü

11.
Cocaine craving and use during pharmacotherapy trials for cocaine use disorder: A multi-trajectory analysis.
Drug and alcohol dependence 2025 PMID:40845736

11. Drug Alcohol Depend. 2025 Oct 1;275:112841. doi: 10.1016/j.drugalcdep.2025.112841. Epub 2025 Aug 15. Cocaine craving and use during pharmacotherapy trials for cocaine use disorder: A multi-trajectory analysis. Mojtabai R(1), Susukida R(2), Farokhnia M(3), Nguyen TQ(2), Leggio L(4), Bergeria

12.
Methylphenidate versus placebo for fatigue in patients with advanced cancer: the MePFAC randomised controlled trial.
Health technology assessment (Winchester, England) 2025 PMID:40755226

12. Health Technol Assess. 2025 Jul;29(36):1-47. doi: 10.3310/GJPS6321. Methylphenidate versus placebo for fatigue in patients with advanced cancer: the MePFAC randomised controlled trial. Stone P(1), Minton O(2), Richardson A(3), Buckle P(1), Enayat ZE(1), Marston L(4), Freemantle N(5). Author

13.
Modafinil alters the functional connectivity of distinct thalamic nuclei with the neocortex.
NeuroImage 2025 PMID:40288703

13. Neuroimage. 2025 May 15;312:121242. doi: 10.1016/j.neuroimage.2025.121242. Epub 2025 Apr 25. Modafinil alters the functional connectivity of distinct thalamic nuclei with the neocortex. Delli Pizzi S(1), Tomaiuolo F(2), Sestieri C(3), Chiarelli AM(3), Gambi F(4), Ferretti A(5), Sensi SL(6).

14.
The observation of seasonal variation of fatigue in multiple sclerosis depends on the measurement instrument.
Multiple sclerosis and related disorders 2025 PMID:39742689

14. Mult Scler Relat Disord. 2025 Feb;94:106252. doi: 10.1016/j.msard.2024.106252. Epub 2024 Dec 28. The observation of seasonal variation of fatigue in multiple sclerosis depends on the measurement instrument. Cordano C(1), Waubant E(1), Nourbakhsh B(2). Author information: (1)Department of Ne

15.
Efficacy of oral modafinil on accelerating consciousness recovery in adult patients with moderate to severe acute traumatic brain injury admitted to intensive care unit: a randomized double-blind clinical trial.
Neurosurgical review 2024 PMID:39724479

15. Neurosurg Rev. 2024 Dec 26;48(1):2. doi: 10.1007/s10143-024-03145-x. Efficacy of oral modafinil on accelerating consciousness recovery in adult patients with moderate to severe acute traumatic brain injury admitted to intensive care unit: a randomized double-blind clinical trial. Zand Z(1),

16.
Modulation of Cerebellar-Cortical Connectivity Induced by Modafinil and Its Relationship With Receptor and Transporter Expression.
Biological psychiatry. Cognitive neuroscience and neuroimaging 2025 PMID:39603413

46. Biol Psychiatry Cogn Neurosci Neuroimaging. 2025 Mar;10(3):304-313. doi: 10.1016/j.bpsc.2024.11.010. Epub 2024 Nov 26. Modulation of Cerebellar-Cortical Connectivity Induced by Modafinil and Its Relationship With Receptor and Transporter Expression. Delli Pizzi S(1), Tomaiuolo F(2), Ferretti

17.
Comparative effectiveness of cognitive behavioural therapy, modafinil, and their combination for treating fatigue in multiple sclerosis (COMBO-MS): a randomised, statistician-blinded, parallel-arm trial.
The Lancet. Neurology 2024 PMID:39424559

7. Lancet Neurol. 2024 Nov;23(11):1108-1118. doi: 10.1016/S1474-4422(24)00354-5. Comparative effectiveness of cognitive behavioural therapy, modafinil, and their combination for treating fatigue in multiple sclerosis (COMBO-MS): a randomised, statistician-blinded, parallel-arm trial. Braley TJ(1

18.
Modafinil Versus Amphetamine-Dextroamphetamine For Idiopathic Hypersomnia and Narcolepsy Type 2: A Randomized, Blinded, Non-inferiority Trial.
CNS drugs 2024 PMID:39306601

10. CNS Drugs. 2024 Nov;38(11):909-920. doi: 10.1007/s40263-024-01122-y. Epub 2024 Sep 21. Modafinil Versus Amphetamine-Dextroamphetamine For Idiopathic Hypersomnia and Narcolepsy Type 2: A Randomized, Blinded, Non-inferiority Trial. Trotti LM(1)(2), Blake T(3), Hoque R(3)(4), Rye DB(3)(4), Shar

19.
Caffeine and modafinil modulate the effects of sleep deprivation on thalamic resting-state functional connectivity: A double-blind pilot study.
Sleep medicine 2024 PMID:39137663

16. Sleep Med. 2024 Oct;122:71-83. doi: 10.1016/j.sleep.2024.08.007. Epub 2024 Aug 8. Caffeine and modafinil modulate the effects of sleep deprivation on thalamic resting-state functional connectivity: A double-blind pilot study. Zhong X(1), Xu L(1), Wang L(1), Chen J(1), Gong X(1), Lian J(1), G

20.
Assessing the longevity of attribute framing in attenuating the nocebo effect to brand and generic medication.
Applied psychology. Health and well-being 2024 PMID:38967323

35. Appl Psychol Health Well Being. 2024 Nov;16(4):2026-2047. doi: 10.1111/aphw.12575. Epub 2024 Jul 5. Assessing the longevity of attribute framing in attenuating the nocebo effect to brand and generic medication. Barnes K(1), Sydney K(1), Petkovich K(1), Hasan Y(1), Koul S(1), Humphreys K(1),

21.
Longitudinal and Seasonal Trends in Reimbursed and Non-Reimbursed Methylphenidate Dispense and Its Most Common Alternatives in Belgium.
Pharmacoepidemiology and drug safety 2026 PMID:42003424

46. Pharmacoepidemiol Drug Saf. 2026 Apr;35(4):e70380. doi: 10.1002/pds.70380. Longitudinal and Seasonal Trends in Reimbursed and Non-Reimbursed Methylphenidate Dispense and Its Most Common Alternatives in Belgium. Van Wichelen N(1), Boogaerts T(1), Raeime A(1), Ferreira LS(1), Gys C(1), Covaci

22.
Advanced modafinil-loaded transethosomes for brain targeting: development, ex-vivo permeation and radio-distribution evaluations.
Drug delivery and translational research 2026 PMID:41996060

17. Drug Deliv Transl Res. 2026 Apr 17. doi: 10.1007/s13346-026-02103-y. Online ahead of print. Advanced modafinil-loaded transethosomes for brain targeting: development, ex-vivo permeation and radio-distribution evaluations. Sayyed ME(1), Ahmed S(2), Attallah KM(1). Author information: (1)Labe

23.
Optimizing cognitive enhancement through dopamine transporter modulation.
Neuropharmacology 2026 PMID:41980668

34. Neuropharmacology. 2026 Apr 12;294:110969. doi: 10.1016/j.neuropharm.2026.110969. Online ahead of print. Optimizing cognitive enhancement through dopamine transporter modulation. Niello M(1), Kalaba P(2), Cybulska-Klosowicz A(3), Kirchhofer M(2), Spreitzer I(2), Spreitzer M(2), Wackerlig-Dam

24.
Prescription psychostimulants, atomoxetine and the risk of psychosis in adults with history of psychosis: a population-based cohort study.
Translational psychiatry 2026 PMID:41916954

31. Transl Psychiatry. 2026 Mar 31;16(1):226. doi: 10.1038/s41398-026-03998-4. Prescription psychostimulants, atomoxetine and the risk of psychosis in adults with history of psychosis: a population-based cohort study. Bach P(1)(2), Franck J(3), Hällgren J(4)(5), Widing H(4)(5), Gissler M(4)(6)(7)

25.
Drug repurposing in the management of major depressive disorder: a perspective.
East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan 2026 PMID:41916942

9. East Asian Arch Psychiatry. 2026 Mar;36(1):46-55. doi: 10.12809/eaap25103. Drug repurposing in the management of major depressive disorder: a perspective. Kulshreshtha V(1), Dixit A(1), Singh CV(1), Mishra AK(1), Kumar V(1), Kaktan K(1). Author information: (1)Department of Pharmacology, UPUM

26.
Dyskinesia following modafinil administration in a patient with autism spectrum disorder and narcolepsy: a case report.
Journal of medical case reports 2026 PMID:41913296

40. J Med Case Rep. 2026 Mar 30. doi: 10.1186/s13256-026-05996-y. Online ahead of print. Dyskinesia following modafinil administration in a patient with autism spectrum disorder and narcolepsy: a case report. Niijima K(1), Kume K(2), Murabayashi N(3), Wakai M(3). Author information: (1)Sleep Me

27.
Involvement of the α(1)-adrenergic receptor in caffeine-induced drug discrimination and conditioned taste avoidance in rats.
Physiology & behavior 2026 PMID:41911998

11. Physiol Behav. 2026 Jul 1;311:115320. doi: 10.1016/j.physbeh.2026.115320. Epub 2026 Mar 28. Involvement of the α(1)-adrenergic receptor in caffeine-induced drug discrimination and conditioned taste avoidance in rats. Rauhut AS(1). Author information: (1)Department of Psychology and Neurosci

28.
Pharmacotherapy in Disorders of Consciousness: A Mechanism-Based Review.
CNS drugs 2026 PMID:41876835

16. CNS Drugs. 2026 May;40(5):623-656. doi: 10.1007/s40263-026-01274-z. Epub 2026 Mar 24. Pharmacotherapy in Disorders of Consciousness: A Mechanism-Based Review. Gillet A(1)(2), Geron C(3)(4), Vitello MM(1)(2)(5), Lejeune N(6)(7)(8). Author information: (1)Coma Science Group, GIGA Institute, Un

29.
Reduced risk of cause-specific hospitalisations and all-cause hospitalisation/mortality during treatment with attention-deficit/hyperactivity disorder medications in the course of bipolar disorder: a Swedish registry-based within-subject cohort study.
BMJ mental health 2026 PMID:41856665

18. BMJ Ment Health. 2026 Mar 19;29(1):e302159. doi: 10.1136/bmjment-2025-302159. Reduced risk of cause-specific hospitalisations and all-cause hospitalisation/mortality during treatment with attention-deficit/hyperactivity disorder medications in the course of bipolar disorder: a Swedish registr

30.
Prader-Willi Syndrome.
1993 PMID:20301505

25. Prader-Willi Syndrome. Driscoll DJ(1), Miller JL(2), Cassidy SB(3). In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026. 1998 Oct 6 [updated 2026 Feb 19]. Author information: (1)Profe

⚠️ 면책 고지

이 정보는 일반 교육 목적이며 의료 진단/처방을 대체하지 않습니다.